Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prudential Jennison Health Sciences Class R (PJHRX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks investments whose price will increase over time. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector. The fund is non-diversified.


1 month-10.76% 3 years+8.67%
3 months-4.99% 5 years--
1 year-11.85% Since inception+18.68%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return--+20.19%
Expense ratio1.58%1.32%
Risk 5 year sharpe ratio1.151.32
Net assets$2.3B$3.2B
Average market cap$14.5B$36.3B
Average P/E28.720.0
Portfolio turnover52%52%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 17 Years
Minimal initial investment$0.00
Minimum IRA investment--


U.S. stock94.45%
International stock2.87%
Fixed income1.85%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical Inc6.47%
CELG Celgene6.04%
SHPG Shire4.90%
AGN Allergan4.74%
UNH UnitedHealth4.53%
INCY Incyte Corp3.68%
AET Aetna3.56%
LLY Eli Lilly and Co3.20%
AERI Aerie Pharmaceuticals Inc3.14%
ALXN Alexion Pharmaceuticals Inc3.07%